Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PURPOSE: We aimed to characterize the antiretroviral therapy (ART) cascade among female sex workers (FSWs) globally. METHODS: We systematically searched PubMed, Embase and MEDLINE in March 2014 to identify studies reporting on ART uptake, attrition, adherence, and outcomes (viral suppression or CD4 count improvements) among HIV-infected FSWs globally. When possible, available estimates were pooled using random effects meta-analyses (with heterogeneity assessed using Cochran's Q test and I2 statistic). RESULTS: 39 studies, reporting on 21 different FSW study populations in Asia, Africa, North America, South America, and Central America and the Caribbean, were included. Current ART use among HIV-infected FSWs was 38% (95% CI: 29%-48%, I2 = 96%, 15 studies), and estimates were similar between high-, and low- and middle-income countries. Ever ART use among HIV-infected FSWs was greater in high-income countries (80%; 95% CI: 48%-94%, I2 = 70%, 2 studies) compared to low- and middle-income countries (36%; 95% CI: 7%-81%, I2 = 99%, 3 studies). Loss to follow-up after ART initiation was 6% (95% CI: 3%-11%, I2 = 0%, 3 studies) and death after ART initiation was 6% (95% CI: 3%-11%, I2 = 0%, 3 studies). The fraction adherent to ≥95% of prescribed pills was 76% (95% CI: 68%-83%, I2 = 36%, 4 studies), and 57% (95% CI: 46%-68%, I2 = 82%, 4 studies) of FSWs on ART were virally suppressed. Median gains in CD4 count after 6 to 36 months on ART, ranged between 103 and 241 cells/mm3 (4 studies). CONCLUSIONS: Despite global increases in ART coverage, there is a concerning lack of published data on HIV treatment for FSWs. Available data suggest that FSWs can achieve levels of ART uptake, retention, adherence, and treatment response comparable to that seen among women in the general population, but these data are from only a few research settings. More routine programme data on HIV treatment among FSWs across settings should be collected and disseminated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America: A Meta-analysis
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., Rachlis, B., Wu, P., Cooper, C., Thabane, L., et al. (2006) · JAMA · doi:10.1001/jama.296.6.679 · Cited by 899
Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding
Graham, S. M., Holte, S. E., Peshu, N. M., Richardson, B. A., Panteleeff, D. D., Jaoko, W. G., Ndinya-Achola, J. O., Mandaliya, K. N., Overbaugh, J. M., & McClelland, R. S. (2007) · AIDS · doi:10.1097/qad.0b013e32801424bd · Cited by 136 · cited 4×
“Estimates of the fraction of FSWs 100% adherent to ART were highest shortly after starting directly observed therapy (91% after 28 days on ART [30]) and at the end of a peer-driven intervention (90.”
BackgroundResultInfluential
Cited by
Iacob, S. A., Iacob, D. G., & Jugulete, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00831 · Cited by 265
Kerrigan, D., Donastorg, Y., Barrington, C., Perez, M., Gomez, H., Mbwambo, J., Likindikoki, S., Mantsios, A., Beckham, S. W., Leddy, A., et al. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00485-3 · Cited by 34
Mbonye, M., Seeley, J., Nalugya, R., Kiwanuka, T., Bagiire, D., Mugyenyi, M., Namale, G., Mayanja, Y., & Kamali, A. (2016) · AIDS Care · doi:10.1080/09540121.2016.1164804 · Cited by 33
“…those attending the clinic in Kampala, have been shown to be capable of adhering at comparable levels with other women in the general population (Mountain et al., 2014), barriers to adherence such as alcohol use, partner change, high mobility, stigma and poor disclosure are important factors in…”
BackgroundKerrigan, D., Karver, T. S., Barrington, C., Donastorg, Y., Perez, M., Gomez, H., Mbwambo, J., Likindikoki, S., Davis, W., Wilson Beckham, S., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03168-1 · Cited by 25
“Prior systematic reviews have revealed that less than half of FSW are estimated to have access to antiretroviral therapy (ART) and among those on ART, there are significant gaps in viral suppression [4].”
Background
Metadata
- Authors
- Mountain, E., Mishra, S., Vickerman, P., Pickles, M., Gilks, C., & Boily, M.-C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-29
- Volume
- 9
- Issue
- 9
- Pages
- e105645
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2024701646
- Cited by
- 138
- References
- 4
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0105645
- The paper
- Mountain, E., Mishra, S., Vickerman, P., Pickles, M., Gilks, C., & Boily, M.-C. (2014). Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0105645
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.